Professor Paul Dietze is one of Australia’s leading alcohol and other drug epidemiologists with a significant national, and emerging international profile. With over 17 years’ experience and an outstanding track record in obtaining competitive grants, his work has established internationally innovative surveillance systems and applied research designs that break new ground in the public health research into alcohol and other drug use and related harms in Australia.
He has produced over 120 journal articles, along with many other reports of significant impact, that have changed practice in the area of alcohol and other drugs in this country. During the course of his research career he has received over $20 million of research funding.
He has been involved in the development and implementation of a variety of heroin overdose prevention initiatives including the Direct Response to Overdose (DROP) project.
He is leading the evaluation of the first Australian bystander naloxone program being implemented in the ACT, and was a key member of the Expanding Naloxone Availability in the ACT Committee. He is a Chief Investigator on a trial of intranasal naloxone in the Sydney Medically Supervised Injecting Centre that commenced in January 2012.
He also currently co-convene the Victorian Injecting Drug Harm Reduction Network with ANEX through which research findings on injecting drug use are disseminated to the alcohol and drug sector.
He has received numerous awards and prizes in recognition of his work.